Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials.

Publication

Citation: Fiore M, Forli S, Manetti F.: Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials. J Med Chem, Volume 59 (8), 2016
Authors: Fiore M, Forli S, Manetti F.
Journal: J Med Chem
Year: 2016
DOI: 10.1021/acs.jmedchem.5b01457
PubMed: 26502061
Machine-readable: REST API RDF

Targeting Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MAPKAPK2, MK2): Medicinal Chemistry Efforts To Lead Small Molecule Inhibitors to Clinical Trials. | MolMeDB